Peptide ChooserMOTS-c vs NAD+
MOTS-c is not approved; NAD+ is pharmacy-made. At the shops we show, NAD+ is cheaper per mg: $0.023/mg against $0.50/mg.
Checked 2 Nov 2026Peptide Chooser editorial team. Statuses come from the FDA lists; prices are the lowest we show, per mg at the shops or per month at the online clinics.
| MOTS-cNot approved | NAD+Pharmacy-made | |
|---|---|---|
| FDA status | Not approvedits nomination for pharmacy compounding was withdrawn. FDA source, 19 Oct 2026 | Pharmacy-madepharmacies may compound it while the FDA reviews it; no approved product. FDA source, 19 Oct 2026 |
| Goal pages | Longevity and energy | Longevity and energy |
| Lowest price at shops | $0.50/mglowest of 10 shops | $0.023/mglowest of 10 shops |
| Clinic plans from | Not applicable | Not applicable |
| Forms sold | vial | vial, spray, nasal spray |
| What the goal page says | A "mitochondrial" peptide sold for energy; animal studies only. Same July 2026 review. | Not a peptide: a vitamin-B3-derived molecule sold by clinics as shots or drips for energy. |
| FDA letters | FDA warning letterslisted by company, not by substance | FDA warning letterslisted by company, not by substance |
| Guides | No guide names it | No guide names it |
Our pages on each: MOTS-c and NAD+. We do not link to the shops or the clinics.